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Chemical and physiological aspects of isomers of conjugated fatty acids
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1 Introduction
Lifestyle factors, including diet, influence the development 
of many non transmissible chronic diseases such as cancer, 
atherosclerosis, inflammation, and obesity (PARK; PARIZA, 
2007). The human diet contains saturated, monounsaturated and 
omega-3 and omega-6 polyunsaturated fatty acids (YANG et al., 
2009). In addition, two types of structurally related conjugated 
octadecaenoic acids, namely, conjugated linoleic acids (CLAs) 
and conjugated linolenic acids (CLNAs), are also present in the 
human diet although in small quantities (YANG et al., 2009). 
It has been noted that the quality of dietary lipids could be an 
important modulator in terms of the morbidity and mortality 
of these diseases (NAGAO; YANAGITA, 2005).
Polyunsaturated fatty acids (PUFAs), such as linoleic 
acid (LA, 18:2, ω-6), α-linolenic acid (LNA, 18:3, ω-3), and 
arachidonic acid (20:4, ω-6) are important for the maintenance 
of biofunctions in mammals. It should be also noted that 
other polyunsaturated fatty acids of omega-series such as 
eicosapentaenoic acid (EPA, 20:5, ω-3) and docosahexaenoic 
acid (DHA, 22:6, ω-3) are correlated with a reduced risk of 
cancer and cardiovascular disease in clinical and animal studies 
(NAGAO; YANAGITA, 2008).
Recently, many studies are focused on ‘conjugated fatty 
acids’ (CFAs), which is the general term for a set of positional 
and geometric isomers of polyunsaturated fatty acids with 
conjugated double bonds (YUAN, G. F.; YUAN, J. Q.; LI, 2009; 
YUAN et al., 2009a). Interest in health benefits of CFAs is 
increasing since they have been shown to possess antioxidant, 
antitumor, immunomodulatory, and serum lipid-lowering 
activity (CAO et al., 2009). According to Tran et al. (2010), 
CFAs are known to have pharmacologic activities relevant to 
the prevention and treatment of atherosclerosis, obesity, cancer, 
and hypertension.
CFAs occur naturally as diene, triene, and tetraene 
compounds (YUAN, G. F.; YUAN, J. Q.; LI, 2009; YUAN et al., 
2009a, c). Theoretically, several CFA isomers are possible 
with multiple combinations of numerical, positional, and 
geometrical configurations of conjugation in double bonds 
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and may have cis or trans configurations (WAHLE; HEYS; 
ROTONDO, 2004; TSOFLIOU et al., 2009). They have been 
detected in milk fat, cheese, and ruminant meat (NAGAO; 
YANAGITA, 2008; SANTOS-ZAGO; BOTELHO; OLIVEIRA, 
2008). CLAs have been the subject of extensive investigations 
for their various biological activities. It has been reported that 
CLAs are antiatherosclerotic, anticarcinogenic, hypotensive, 
(NAGAO; YANAGITA, 2008). There are CFAs of linoleic acid 
and α-linolenic (KOBA; BELURY; SUGANO, 2007). Figure 1 
shows some of these isomers. 
The conjugated fatty acids of linoleic acid (CLAs) 
comprise a group of positional and geometrical isomers of 
octadecadienoic acid (18:2 ω–6) in which the two double 
bonds are conjugated (without methylene interruption) 
Figure 1. Structures of geometric and positional isomers of CFAs (adapted of TRAN et al., 2010).
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Butyrivibrio fibrisolvens in ruminants such as cows, sheep, 
goats, and camels (NAGAO; YANAGITA, 2008). An alternative 
source of cis9, trans11 CLA isomer is by Δ-9 desaturation of 
trans11 vaccenic acid in mammalian tissues. The other main 
isomer of CLAs, trans10, cis12, is present in food in negligible 
amounts (PARK; PARIZA, 2007). The cis9, trans11 isomer, also 
known as rumenic acid, is the predominant form of CLA found 
in naturally occurring foods. Cis9, trans11 CLA comprises 
approximately 90% of the CLA found in ruminant meats and 
dairy products, and the trans10, cis12 isomer comprises the 
remaining 10%. Although several other isoforms of CLAs have 
been identified (trans9, trans11; cis9, cis11; trans10, trans11 
and cis10, cis12), the cis9, trans11 and trans10, cis12 isomers 
appear to be the most biologically active (WALLACE et al., 
2007; KENNEDY et al., 2010). 
Several factors influence the CLAs content of food products, 
animal’s diet, age or breed, and seasonal factors (RAINER; 
HEISS, 2004). The content of CLAs in milk ranged from 7.3 to 
9.0 mg.g-1 of milk fat depending on the diets fed to cows (HUR; 
PARK; JOO, 2007), and within beef muscle concentrations of 
CLAs have been found to range from 0.37 to 1.08 g.100 g-1 
(McAFEE et al., 2010). In the United States, it was estimated 
that a 70 kg individual should consume 3.0 g CLA/day to obtain 
beneficial effects from CLAs. This amount is about three times 
larger than that of the daily CLAs consumption of average adults 
(HUR; PARK; JOO, 2007). The average daily intake of CLAs is 
approximately 152 and 212 mg for non-vegetarian women and 
men, respectively, and human serum levels range from 10 to 
70 μmol.L-1 (KENNEDY et al., 2010). Large amounts may be 
consumed in the form of supplements since CLAs are claimed 
to cause weight loss, and supplement manufacturers recommend 
doses of 3.0-3.4 g/day for this purpose (WANDERS et al., 
2010).
Linoleic acid can be converted to CLAs when a microbial 
or chemical reaction shifts the double bonds to form alternating 
double and single bonds, hence the term: conjugated linoleic 
acid (RAINER; HEISS, 2004). CLAs are produced commercially 
by alkaline isomerization of LA-rich oils and tend to contain an 
equimolar mixture of the cis9, trans11 and trans10, cis12 isomers 
(NAGAO; YANAGITA, 2008). There is no structural difference 
between naturally existing CLAs and synthetic CLA isomers 
(KRAMER et al., 1998; HUR; PARK; JOO, 2007).
Commercial preparations of CLAs are obtained from 
the linoleic acid of safflower or sunflower oils under alkaline 
conditions. This type of processing yields a CLAs mixture 
containing approximately 40% of the cis9, trans11 isomer and 
44% of the trans10, cis12 isomer. Commercial preparations 
also contain approximately 4 – 10% trans9, trans11 CLA and 
trans10, trans12 CLA, as well as trace amounts of other isomers 
(KENNEDY et al., 2010).
2.2 Incorporation and metabolism 
Since their discovery, CLAs has been studied consistently 
and thoroughly in relation to metabolism, incorporation, and 
beneficial properties to health (SANTOS-ZAGO; BOTELHO; 
OLIVEIRA, 2008). The rate of CLAs metabolism in rats varies 
antilipogenic, immunoenhancing, and antioxidative (KOBA; 
BELURY; SUGANO, 2007; ANDREOLI et al., 2009; YANG et al., 
2009). 
The conjugated α-linolenic acids (CLNAs) are other types of 
CFAs, which have 18 carbons and three double bonds conjugated 
together (YUAN et al., 2019a). The three double bonds present 
in CLNAs are primarily in positions Δ9, 11, 13 and Δ8, 10, 
12 and exist in both cis and trans geometrical isomer forms 
(KÝRALAN; GÖLÜKCÜ; TOKGÖZ, 2009; SASSANO et al., 
2009). Many seed oils can be found in nature, and they have 
proved to be a potent suppressor of the growth of various 
human tumor cells and alter the lipid metabolism in animals 
(YANG et al., 2009; YUAN et al., 2009e). 
In recent decades, interest in CFAs has increased due to 
their many bioactive properties related to health. There are 
many studies evaluating the beneficial effects of CLAs to the 
body, especially in some experimental animal models. However, 
some results are controversial and even show other adverse 
effects. In addition, the effects in humans are still questionable, 
and the biochemical mechanisms through which CLAs mediate 
the potential effects could produce undesirable metabolic 
alterations (ANDREOLI et al., 2009). In this sense, Agência 
Nacional de Vigilância Sanitária (ANVISA - Brazilian Health 
Vigilance Agency) banned the sale of supplements containing 
CLAs due to the lack of conclusive scientific studies regarding 
their safety and efficacy (BRASIL, 2007). Compared with CLAs, 
studies dealing with the physiological effects of CLNAs are still 
limited (KOBA; BELURY; SUGANO, 2007). There is no report 
that has estimated the current intake of CLNAs by humans and 
it is also uncertain whether CLNAs have health benefits similar 
to those of CLAs and LNA (YANG et al., 2005). In this study, 
we review the conjugated fatty acids in terms of their potential 
health effects. 
2 Conjugated Linoleic Acids (CLAs)
2.1 Structure, isomers and sources
Numerous fatty acids with conjugated double bonds occur 
naturally in fats derived from ruminant animals, such as milk, 
milk products, meat, and meat products (BENJAMIN; SPENER, 
2009). The term conjugated linoleic acid (CLA) refers generically 
to the class of positional and geometric conjugated dienoic 
isomers of linoleic acid (PARIZA; PARK; COOK, 2001) with 
double bonds at [9, 11], [10, 12], [8, 10], [7, 9], and [11, 13] 
positions. Although a number of CLAs isomers are found in 
food (KRAMER et al., 1998; YUAN et al., 2009c), the primary 
focus of this research is on the two main isomers, cis9, trans11 
and trans 10, cis 12 (PARK; PARIZA, 2007).
The microbiota presented in the gastrointestinal tract of 
ruminant animals converts linoleic acid into different isoforms 
of CLAs through biohydrogenation. This process changes 
the position and configuration of the double bonds resulting 
in a single bond between two double bonds [cis9, trans11 
or trans10, cis12 octadecadienoic acid] (KENNEDY et al., 
2010). The cis9, trans11 CLA isomer is produced through the 
biohydrogenation of unsaturated fatty acids by the bacterium 
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As mentioned earlier, the incorporation of CLAs and some 
of their metabolites into neutral lipids results in the accumulation 
in tissues that are particularly rich in those lipids, such as 
mammary and adipose tissue (BANNI, 2002). The CLAs, when 
supplemented in the diet of the mother may be incorporated by 
cells in the mammary gland and secreted in the breast milk. Breast 
milk of women fed CLAs-enriched cookies (CLAs 1,912 mg) 
was analyzed and enrichment of CLAs in milk for 48 hours after 
ingestion of cookies enriched with CLAs was 2.9 times above the 
control (231 mg CLAs) (MOUTSIOULIS et al., 2008). 
Data concerning the normal concentrations of CLAs in 
human plasma (ZLATANOS; LASKARIDIS; SAGREDOS, 2008), 
mammary gland, breast milk (MOUTSIOULIS et al., 2008), and 
on the incorporation of CLAs in adipose tissue and skeletal muscle 
(GOEDECKE et al., 2009) are scarse. This kind of information 
could help to estimate whether a person takes satisfactory 
amounts of CLAs with the diet or there is a need to increase them 
by supplementation given its potential effects on health-related 
parameters (ZLATANOS; LASKARIDIS; SAGREDOS, 2008).
2.3 Health effects
Since the discovery of CLAs as grilled beef-derived 
antimutagen in the 1980s, around 50% of the studies concerning 
physiological functions of CFAs has been focused on their 
anticarcinogenic properties. However, there has been an 
increasing number of reports about antiobesity, antiatherogenic, 
antidiabetic, and hypotensive properties of CFAs in animal 
and human studies (NAGAO; YANAGITA, 2008; PARK, 2009; 
KENNEDY et al., 2010).
Researchers have been aware of CLAs for decades, but 
it became a subject of intense search only after the discovery 
that they have antimutagenic activity (PARK; PARIZA, 2007). 
They have also proved to have antiatherosclerotic (MITCHELL; 
McLEOD, 2008) and antiobesity properties (KENNEDY et al., 
2010), besides improving insulin resistance in rats (ZHOU et al., 
2008). More notably, they have been found to act as a potent 
cancer preventive agent in animal models of chemical 
carcinogenesis in skin, forestomach, colon, breast, and liver 
(PARK, 2009).
CLAs are known to exert several isomer-specific biological 
effects, but their mechanisms of action are unclear (PARK; 
PARIZA, 2007). More recently, CLAs have shown to undergo 
elongation and desaturation processes similar to those that occur 
with linoleic acid. This suggests that the CLAs mechanisms of 
action may be directly related to their properties and metabolism 
as unsaturated fatty acids (CZAUDERNA; KOWALCZYK; 
KORNILUK, 2007; SUBBAIAH et al., 2010). 
Weight gain, body composition, lipids  
profile, and insulin resistance index
Supplementation with a mixture of CLA isomers or trans10, 
cis12 CLA alone was capable to reduce adiposity in animal 
models, especially in rodents, but this effect was observed only 
in a few human studies. Potential mechanisms responsible 
for antiobesity properties of trans10, cis12 CLA include: 
decrease energy intake by suppressing appetite; increase energy 
in different tissues and it is sensitive to experimental conditions, 
specially the dietary supply of linoleic acid. In adipose and 
mammary tissues, the metabolite content ranges from 5 to 
15% of total CLAs and in plasma and liver from 10 to 30% 
(BANNI, 2002). CLAs, like other PUFAs, have been shown 
to be incorporated into membrane lipids with the extent of 
incorporation ranging from <1 to >50% of total phospholipid 
fatty acids in various cells (SUBBAIAH et al., 2010).
The cis9, trans11-18:2 and trans10, cis12-18:2 were 
incorporated into all mouse tissues (liver, kidney, heart, perirenal 
adipose tissue, and spleen) examined in the group that received 
1.0% CLA incorporated into the diet at levels ranging from 0.5 to 
2.0% of tissue fatty acids. The proportions of 20:4 n-6 and 22:6 n-3 
were significantly reduced in liver and kidney by CLAs feeding. 
In the heart, 22:6 n-3 content was also reduced by CLA feeding 
although not significant (YUAN et al., 2009c).
Rats fed diets with 2% CLAs isomer mixture had feed intake 
and body weight gain reduced, while addition of trans10, cis12 
CLA and Selenized-yeast resulted in the highest body weight gain. 
CLAs supplementation generally elevated the concentration of 
CLA isomers in heart and muscles significantly although cis9, 
trans11 CLA accumulated preferentially. The dietary enrichment 
with CLA isomers caused a reduction in the Δ9-desaturase 
capacity. Furthermore, CLA isomers supplementation decreased 
the total fatty acids and PUFA concentrations in heart and muscles 
compared with control rats. Moreover, addition of CLA isomers 
interfered in the conversion of linoleic and linolenic acids to 
higher metabolites due to the competition of CLA isomers for the 
same enzymes such as Δ6–, Δ5–, Δ4– desaturases, and elongase 
(CZAUDERNA; KOWALCZYK; KORNILUK, 2007).
The first step towards understanding the clinical effects 
of CLAs supplementation in humans is to determine which 
tissues may be enriched with these compounds in response 
to supplementation. Few studies have investigated the in vivo 
effects of CLAs supplementation in humans on tissue-specific 
CLA isomers incorporation (GOEDECKE et al., 2009). The 
results of studies carried out by Zlatanos, Laskaridis and Sagredos 
(2008) showed that CLAs had less effect on body fat than it was 
concluded from in vivo studies. However, Goedecke et al. (2009) 
have shown that a daily supplementation with 3.9 g CLAs (50:50, 
trans10, cis12: cis9, trans11) during 12 weeks increases the content 
of the trans10, cis12 isomer in the adipose tissue triacylglycerol 
and the cis9, trans11 isomer tended to increase in skeletal muscle 
phospholipids.
Based on the results of the study conducted by Zlatanos, 
Laskaridis and Sagredos (2008) on a comparison between the 
plasma CLAs content of individuals who do not consume dairy 
products, and those who consume normal amounts of dairy 
products and individuals who consume CLAs supplement, the 
only CLA isomers that presented higher percentage than the 
detection limit (0.03% of total fatty acids) was the rumenic acid 
(cis9, trans11 octadecadienoic acid). An interesting finding is 
that compared to the other two groups, the CLAs supplemented 
group show the highest rumenic acid content in plasma (0.2% of 
total fatty acids). With regard to this result, it could be suggested 
that the lower limit of the plasma CLAs content is approximately 
0.1% of total fatty acids. 
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Antioxidant activity
The effect of CLAs on lipid autoxidation processes has been 
studied extensively in recent years, with some ambiguous results, 
which do not allow clear conclusions about the antioxidant 
action. The presence of double bonds in the trans configuration 
of CLA isomers contribute to the stability of autoxidation, but 
considering that the conjugation of double bonds would be the 
beginning of lipid autoxidation, CLAs could act as pro-oxidant 
(SANTOS-ZAGO; BOTELHO; OLIVEIRA, 2008). According 
to Fagali and Catalá (2008), some authors showed that CLAs 
had antioxidant activity and it could be a possible explanation 
for the anticarcinogenic and antiatherogenic effects, while other 
investigations have pointed CLAs as pro-oxidants. 
The in vitro studies that evaluate the oxidative stability of 
CLAs are conclusive with the fact that CLAs are more stable 
than other PUFAs that have no trans double bonds (SANTOS-
ZAGO; BOTELHO; OLIVEIRA, 2008). However, Yang et al. 
(2009) compared the oxidative stability of individual CLA 
isomers with their corresponding nonconjugated, LA, and 
concluded that CLAs had greater oxidative instability than LA. 
Meantime, Fagali and Catalá (2008) demonstrated that CLAs 
also have antioxidant properties. Different concentrations of 
fat acid were investigated for free radical scavenging properties 
against the stable radical (DPPH•). Both CLA isomers reacted 
and quenched DPPH• at all tested concentrations (from 5 to 
25 mM), while LA and methyl linoleate (LAME) did not show 
radical quenching activity even at the highest concentration. 
These data indicate that CLAs would provide protection against 
free radicals, but LA and LAME would not.
The evaluation of the CLAs antioxidant activity in animals is 
undertaken by the determination of thiobarbituric acid reactive 
substances (TBARS) and antioxidant enzymes, such as catalase 
(CAT), superoxide dismutase (SOD), and glutathione peroxidase 
(GSH-Px) (SANTOS-ZAGO; BOTELHO; OLIVEIRA, 2008). 
Mice fed a high fat diet and 3% CLAs mixture showed that 
lipid peroxidation (LPO) using TBARS method, tended to 
normalization when compared with animals fed a high fat diet, 
and this result is related to a significant (85%) increase in the 
glutathione content. The activity of GSH-Px and CAT was not 
increased by CLAs, these enzymes might contribute minimally 
to the lower LPO values observed (ANDREOLI et al., 2009). 
In another study conducted by our research group, rats were 
supplemented with CLAs in the concentrations of 1, 2 and 4% 
based on average daily consumption of diet by gavage, and the 
analysis of TBARS in serum indicated higher peroxidation in 
the 4% CLA group. The evaluation of antioxidant enzymes 
activity showed higher values of GSH-Px in the brain and 
the same was observed for SOD in the brain and liver for 2 
and 4% CLA groups indicating possible antioxidant activity 
(CARVALHO et al., 2009).
Another study conducted by Rahman et al. (2009) fed 
mice with 0.5% cis9, trans11 CLA, 0.5% trans10, cis12 CLA, 
or 0.5% CLA-mix for 6 months showed significantly higher 
muscle mass in both trans10, cis12 CLA and CLA-mix groups. 
An enhanced mitochondrial ATP production, with higher 
membrane potential, and elevated muscle antioxidant enzymes 
(CAT and GSH-Px) production, accompanied by a slight 
expenditure in white adipose tissue, muscle and liver or lean body 
mass; decrease lipogenesis or adipogenesis; increase lipolysis or 
delipidation; and apoptosis via adipocyte stress, inflammation, 
and/or insulin resistance (KENNEDY et al., 2010). CLAs reduced 
the total cholesterol (TC), triacylglycerides (TG), low-density 
lipoprotein cholesterol (LDL-C), and increased high-density 
lipoprotein cholesterol (HDL-C) in different animal models. 
CLAs affect these parameters through reduced blood pressure 
or involvement of peroxisome proliferator activated receptor 
(PPAR, key for lipogenesis), sterol regulatory element binding 
proteins (SREBPs, key for fatty acid synthesis and elongation), 
and/or steroyl-CoA desaturase (SCD, key for TG and cholesterol 
formation) (BHATTACHARYA et al., 2006; PARK, 2009). 
Wistar rats supplemented with LA or CLAs for 42 days 
and the animals fed CLAs had a mean body fat reduction 
of 18% Water, whole body protein and ash content of rats 
supplemented with CLAs were statistically higher relative to 
control group (LA), but levels of triacylglycerols did not change 
after supplementation with CLAs (BOTELHO; SANTOS-
ZAGO; OLIVEIRA, 2008). However, focusing on investigate 
the effects of CLAs at high fat levels, Andreoli et al. (2009) 
found hepatomegaly and exacerbation of lipid accretion 
to be a negative impact, but some positive aspects such as 
hypotriglyceridemia and protection against oxidative stress were 
also observed. Even the fat reduction is nutritionally important 
for weight control, the biochemical mechanisms whereby 
CLA mediates the potential effects could produce undesirable 
metabolic alterations. 
Concerning the animal trials, CLAs in conjugation with 
saturated fats revealed both beneficial and deleterious biological 
effects. In the normal-weight Wistar rat fed a palm oil based diet, 
the administration of cis9, trans11 CLA isomer increased the 
serum triacylglycerols, the size of adipocytes from epididymal, 
and retroperitoneal fat depots. In addition, a CLAs mixture of 
cis9, trans11 and trans10, cis12 isomers increased the glycerol 
membrane permeability of kidney proximal tubules, which 
may indicate an improvement of glycerol reabsorption pathway. 
The CLAs supplementation of diets rich in saturated fats and 
cholesterol has some beneficial effects in obese Zucker rats by 
increasing adiponectin and decreasing plasminogen activator 
inhibitor-1 (PAI-1) serum levels, as well as alleviating hepatic 
steatosis through hepatic lipids reduction. These results were 
highly associated with trans10, cis12 isomers. However, this 
decrease does not seem to be enough to improve insulin 
sensitivity (MARTINS et al., 2010).
Some studies in rats and humans showed that CLAs promote 
insulin resistance, and there are conflicting reports on the effects 
of CLAs on peroxisomal proliferator activated receptor-γ 
(PPARγ) activation and expression. The supplementation with 
CLAs reduces body weight gain and white fat pad weight in the 
rats significantly; at the same time plasma free fatty acids (FFA), 
TG, TC, leptin, insulin, and glucose levels in the obese rats also 
decreased. Moreover, a supplementation with CLAs ameliorate 
insulin resistance by increasing the mRNA expression of PPARγ, 
fatty acid binding proteins (ap2), fatty acid transporter protein 
(FATP), acyl-CoA synthetase (ACS), and adiponectin in the 
adipose tissues of obese rats (ZHOU et al., 2008).
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YUAN et al., 2009b, c). However, according to Sassano et al. 
(2009), seven species of CLNAs are commonly known, adding 
the β-eleostearic acid (β-ESA, trans9, trans11, trans13-18:3) and 
β-calendic acid (trans8, trans10, trans12-18:3) to those already 
mentioned above.
There are specific CLNA isomers in selected plant seeds, 
frequently as major fatty acids. Each of these plant seeds has 
a specific conjugase enzyme, which converts linoleic acid into 
CLNA. Therefore, each plant seed accumulates only a single 
CLNA isomer (KOBA; BELURY; SUGANO, 2007). For example, 
punicic acid is present in the pomegranate seed oil, α-eleostearic 
acid in bitter gourd oil and tung seed oil, catalpic acid in catalpa 
seed oil, and calendic acid in pot marigold seed oil at about 72, 
60–70, 31, and 33% of total fatty acid, respectively (NAGAO; 
YANAGITA, 2008). Therefore, these plant seed oils are suitable 
sources to investigate the physiological functions of individual 
CLNA isomers (KOBA; BELURY; SUGANO, 2007).
Among the seeds containing CLNAs, only those of 
Trichosanthes kirilowii Maxim (TK seeds) from China are edible. 
The punicic acid-harboring TK seeds, at about 32 to 40%, are a 
popular snack food in China (MUKHERJEE et al., 2002; YUAN, 
G. F.; YUAN, J. Q.; LI, 2009; YUAN et al., 2009a, b). 
Like CLAs, CLNAs can be also formed during the 
processing of vegetable oils as a result of the isomerization or 
dehydration of secondary oxidation products of LA and LNA 
(KINAMI et al., 2007; CAO et al., 2009; YANG et al., 2009). 
Although alkaline isomerization is effective for mass-production 
of CLNAs, identification of the detailed profiles of the synthetic 
CLNAs is difficult because the resultant mixture is composed of 
many different CLNA isomers. Nevertheless, synthetic CLNAs 
have proved to exert several physiological functions that are 
important and unique (KOBA; BELURY; SUGANO, 2007). 
Moreover, Coakley et al. (2009) showed that five bifidobacteria 
strains from human intestinal origin converted LNA to CLNAs 
and speculated that the ability of bifidobacteria originated from 
the human intestine to biosynthesis biologically active lipids 
such as cis9, trans11 CLA and CLNA may be related to their 
suggested therapeutic effects.
3.2 Incorporation and metabolism
The study performed by Plourde et al. (2006) demonstrated 
that an equimolar mixture of two CLNA isomers, cis9, trans11, 
cis15-18:3 and cis9, trans13, cis15-18:3 had the same apparent 
absorption efficiency than cis9, trans11-18:2 when ingested 
under nutritional and physiological conditions. Both CLNA 
isomers were mainly incorporated into neutral lipids, but they 
were not metabolized to CLAs. They were metabolized by the 
elongation/desaturation pathway similar to LNA with the cis9, 
trans11, cis15-18:3 isomer being converted into conjugated 
22:6 n-3 and with the cis9, trans13, cis15-18:3 isomer being 
converted into conjugated 20:5 n-3. Yuan et al. (2009e) showed 
that the proportion of 22:6 n-3 was significantly increased in 
liver phospholipids of mice supplemented with 1% PA, but 
not with α-ESA, for 6 weeks. This is consistent with the study 
of Koba et al. (2007) showing that feeding 0.5% pomegranate 
seed oil containing PA increased the proportion of 22:6 n-3 
increase in H2O2 production was noted in trans10, cis12 CLA 
and CLA-mix groups when compared to control (10% corn oil) 
and cis9, trans11 CLA groups. Oxidative stress, as measured 
by serum malondialdehyde and inflammation, as measured 
by LPS-treated splenocyte IL-6 and TNF-α, were significantly 
less in CLA isomers groups. These data indicate that CLAs may 
maintain redox balance during aging process (RAHMAN et al., 
2009).
Research on CLAs has drawn much attention in the last 
years, but how these fatty acids of relatively simple structures 
could have such variety of functions remains unknown. 
Therefore, further studies are needed to clarify the mechanisms 
of CLAs activities (FAGALI; CATALÁ, 2008; SANTOS-ZAGO; 
BOTELHO; OLIVEIRA, 2008; ANDREOLI et al., 2009; PARK, 
2009; RAHMAN et al., 2009).
Molecular actions
In vitro and in vivo studies have demonstrated a range 
of molecular mechanisms through which CLAs act including 
alteration of eicosanoids synthesis, reduction of NF-κB signalling 
proteins, and activation of PPARγ (REYNOLDS; ROCHE, 
2010). It is suggested that CLAs may be involved in reducing 
eicosanoids production, interfering with cell signaling pathways, 
inhibiting DNA synthesis, enhancing apoptosis, and inhibiting 
angiogenesis as shown in reduced matrix metalloproteinase and 
vascular endothelial growth factors (BHATTACHARYA et al., 
2006; PARK, 2009).
Zhou et al. (2008) demonstrate that CLAs are able to increase 
PPARγ activity. Furthermore, CLAs increase gene expression of 
PPARγ and PPARγ target genes ap2, FATP, FAT, and adiponectin 
in white adipose tissue, and reduce the PPARγ target genes 
and leptin levels. Because CLAs improve body fat and serum 
lipid biochemistry parameters, determine the mechanisms of 
action for CLAs can provide molecular targets that may have 
significant impact for many related lipid-dependent diseases, 
such as obesity and Type II diabetes. Thus, it will be of great 
interest to further understand the importance of CLAs as a 
PPARγ modulator in relation to these diseases. 
3 Conjugated Linolenic Acids (CLNAs)
3.1 Structure, isomers and sources
Conjugated linolenic acids (CLNAs) is a collective term for 
the positional and geometric isomers of octadecatrienoic acid 
(C18:3). The three double bonds present in CLNAs are primarily 
in positions Δ9,11,13 and Δ8,10,12 and exist in both cis and trans 
geometrical isomer forms (SASSANO et al., 2009). CLNAs have 
been reported to occur in terrestrial plant lipids, especially seed 
oils (KINAMI et al., 2007), present in high amounts accounting 
for 40-80% of total fatty acids (YANG et al., 2005; ARAO et al., 
2004b). Five CLNA isomers occur as components of major seed 
oils of several plants: α-eleostearic acid (α-ESA, cis9, trans11, 
trans13-18:3), punicic acid (PA, cis9, trans11, cis13-18:3), 
calendic acid (trans8, trans10, cis12-18:3), jacaric acid (cis8, 
trans10, cis12-18:3), and catalpic acid (trans9, trans11, cis13-
18:3) (IWABUCHI; KOHNO-MURASE; IMAMURA, 2003; 
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further studies are needed to provide a clearer understanding 
of this mechanism of CLNAs metabolism (YUAN, G. F.; YUAN, 
J. Q.; LI, 2009). These results indicate that CLNA isomers are 
discriminately metabolized and incorporated. 
Cao et al. (2009) reported that the incorporation of three 
CLNA isomers into the milk in rats was selective. A mixture 
of CLNA isomers including cis9, trans11, trans13-18:3, trans9, 
trans11, trans13-18:3 and cis9, trans11, cis13-18:3 was added 
into the maternal diets, and the results showed that cis9, trans11, 
cis13 CLNA (one trans bond) was the most incorporated into 
the milk followed by cis9, trans11, trans13 (two trans double 
bonds) and trans9, trans11, trans13 (three trans double bonds) in 
a decreasing order. The results suggest that the oxidoreductase of 
Δ13-saturation preferred substrates with a trans configuration. 
The most interesting observation was that feeding maternal rats 
with CLNAs diet could produce milk containing CLA indicating 
that CLNAs were converted into CLA. 
The observation that CLNAs could be converted into cis9, 
trans11 CLA has gained increased importance since it has been 
demonstrated that cis9, trans11 CLA can exert many biological 
activities. Since the α-ESA and PA are present in some plant 
seeds, such as Trichosanthes kirilowii (TK), pomegranate, 
and bitter melon seed in large amounts and could be purified 
relatively easily, they could be alternative sources for obtaining 
the health effects of CLAs (YUAN, G. F.; YUAN, J. Q.; LI, 2009; 
YUAN et al., 2009c). Moreover, natural resources containing 
CLNAs could be a potential dietary source of CLA and are 
expected to be useful as a functional food and nutraceutic.
There are few literature data on the incorporation 
and metabolism of CLNAs in humans. Yuan et al. (2009a) 
investigated the incorporation and metabolism of PA in healthy 
young humans (n = 15). After daily consumption of TK seeds 
containing 3 g of PA for 28 days, the proportion of PA increased 
0.47% in plasma and 0.37% in red blood cell membranes 
(RBCM), respectively. Moreover, the proportion of cis9, 
trans11-18:2 was increased from 0.05 to 0.23% in plasma and 
from 0.03 to 0.17% in RBCM, respectively. The results suggest 
that PA can be effectively incorporated into human plasma and 
RBCM, and it is also associated with the increasing proportion 
of cis9, trans11-18:2 in humans, presumably as a result of the 
metabolism by a saturation reaction.
The biological impact of these fatty acids ingestion needs to 
be considered since they could interfere with lipid metabolism 
and exert other health effects.
3.3 Health effects
Information concerning the biological activity of CLNAs is 
scarce, except for some studies which have demonstrated that 
CLNAs have a cytotoxic effect on cultured human tumor cells 
(IGARASHI; MIYAZAWA, 2005; YASUI et al., 2005), inhibits 
carcinogenesis (KOHNO et al., 2004a, b; TSUZUKI et al., 2004a; 
TSUZUKI; KAWAKAMI, 2008), and alters lipid metabolism 
in animals (YANG et al., 2005; YAMASAKI et al., 2006; 
KOBA et al., 2007; LAM et al., 2008). Some mechanism of 
the antitumor effects of CLNAs is thought to be the apoptosis 
in mouse liver. However, Noguchi et al. (2001) found that the 
supplementation with bitter melon seed oil containing α-ESA 
for 4 weeks increased the proportion of 22:6 n-3 in rat liver. 
Nevertheless, most studies show that CLNAs are well 
absorbed into the body and metabolized to CLA in vivo 
(TSUZUKI et al., 2004b, 2006; KOBA; BELURY; SUGANO, 
2007; YUAN, G. F.; YUAN, J. Q.; LI, 2009). These findings have 
led to an increased interest in CLNAs. 
Studies have shown that α-ESA and PA were detected in 
rodents fed α-ESA and PA, respectively, and the cis9, trans11-
18:2 was detected in the tissues (liver, kidney, heart, adipose 
tissue, spleen, mammary gland, and intestine) of both groups 
(TSUZUKI et al., 2004b, 2006; YANG et al., 2009; YUAN et al., 
2009c, d, e). Therefore, α-ESA or PA could exert beneficial 
activities through the effect of their metabolite (cis9, trans11-
18:2) or the own compounds (α-ESA or PA) per se. Those 
authors also speculated that CLNAs can be converted to CLA 
by a Δ13- saturation reaction carried out by an NADPH-
dependent enzyme that is either a novel enzyme recognizing 
conjugated trienoic acid or the enzyme active in the leukotriene 
B4 reductive pathway. 
Tsuzuki et al. (2006) investigated the absorption and 
metabolism of CLNAs (α-ESA and PA) in rat intestine using 
a lipid absorption assay in lymph from the thoracic duct. The 
results indicate that the α-ESA and PA are slowly absorbed in 
an unchanged state in the rat intestine, and a portion of these 
fatty acids is quickly converted to CLA. Similar results were also 
found by Yuan, G. F., Yuan, J. Q. and LI (2009), which showed 
that PA was also quickly converted into cis9, trans11 CLA in 
different rat tissues and plasma. They observed that no CLA 
and PA were detected immediately after treatment (zero-time), 
but both were detected in the rat tissues and plasma 4, 8, 12, 
and 24 hours after treatment (each rat was fed about 645 mg of 
PA). PA and CLA in the liver and plasma were higher than in 
the brain, heart, kidney, and adipose tissue. 
Yuan et al. (2009d, e) showed still that the accumulation of 
PA in the tissues examined was significantly higher than α-ESA 
and found that the relative conversion rate of α-ESA into cis9, 
trans11-18:2 was significantly higher than that of PA into cis9, 
trans11-18:2 in liver TG and phospholipids, provided further 
evidence that α-ESA is more effectively saturated in the Δ13-
double bond than PA in mouse liver TG and phospholipids. The 
highest conversion rate of α-ESA was found in the adipose tissue 
(91.8%), spleen (91.4%) and kidney (90.7%), and the lowest in 
heart (84.6%); the highest conversion rate of PA occurred in 
the liver (76.2%) and the lowest occurred in the heart (54.5%) 
(YUAN et al., 2009d). The only difference between α-ESA and 
PA is the geometrical structure of the Δ13-double bond since 
α-ESA is a trans double bond, whereas that of PA is a cis double 
bond. Therefore, it is possible that the geometrical structure 
of the Δ13-double bond affects the saturation activity of the 
enzyme, and the difference in the conversion rates of α-ESA and 
PA in vivo was due to substrate-specific effect of this enzyme 
(YUAN, G. F.; YUAN, J. Q.; LI, 2009); YUAN et al., 2009e). It 
is speculated that the liver could be the source of the enzymes 
responsible for the conversion of CLNAs to CLA. However, 
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not alter TC and LDL-C but reduced TG and TG:HDL-C ratio 
during 4 weeks. Further longer studies using larger samples 
are necessary to confirm the effects of PSO and its related 
mechanisms.
Hontecillas et al. (2008) showed that dietary supplementation 
of mice with catalpic acid, an isomer of CLNA, for 78 days 
improved fasting glucose and insulin concentrations and 
enhanced the ability to normalise plasma glucose concentrations 
following a glucose tolerance test in a model of diet-induced 
obesity. These findings were also found by the same authors 
when evaluating mice receiving PA, another CLNA isomer 
(HONTECILLAS et al., 2009). McFarlin, Strohacker and 
Kueht (2009) concluded in their study that PSO intake 
(average consumption of 61.79 mg.d-1) was associated with an 
improvement in insulin sensitivity in CD-1 mice suggesting 
that the risk of developing type 2 diabetes may have been 
reduced. However, dietary supplementation with Trichosanthes 
kirilowii Maxim (TK seeds) rich in PA for 28 days did not have a 
significant effect on fasting serum concentrations of insulin and 
glucose, neither on insulin sensitivity, assessed using the specific 
HOMA-IR index in humans (YUAN et al., 2009c).
Antioxidant activity
Nutritional antioxidants in diseases related to oxidative stress 
have gained a great interest in recent years (SAHA; GHOSH, 
2009). Studies showed that CLNAs suppress the growth of 
tumor cells through a mechanism that involves lipoperoxidation 
(IGARASHI; MIYAZAWA, 2000; TSUZUKI et al., 2004a). 
Grossmann et al. (2009) found that when breast cancer cells 
were treated with α-ESA in the presence of the antioxidant 
α-tocotrienol (20 μmol.L-1), the growth inhibition and apoptosis 
effects of α-ESA were lost. Thus, they concluded that α-ESA 
can block breast cancer cell proliferation and induce apoptosis 
through a mechanism that may be oxidation dependent. 
Although the mechanism of CLNAs bioactivities is considered to 
be related to oxidation, many controversial results are reported 
(YANG et al., 2009). Dhar et al. (2006) concluded that dietary 
CLNA exerts antioxidant activity, as evidenced by reduced lipid 
peroxidation in chemically induced diabetes mellitus.
The non conjugated unsaturated fatty acid structures are 
more susceptible to oxidation process since the presence of 
methylene carbons between the double bonds facilitates the 
removal of hydrogen atom and the formation of free radical, 
which is the initial step for oxidation (MANCINI; MANCINI-
FILHO, 2005). Yang et al. (2009) studied the oxidative stability 
of individual CLNA isomers comparing the oxidative stabilities 
with their corresponding nonconjugated LNA, and concluded 
that CLNAs are more susceptible to autoxidation than LNA. 
Among the three groups of CLNA isomers, the t,t,t-CLNA 
isomers had greater stability followed by c,t,t-CLNA and c,t,c-
CLNA isomers in decreasing order. The oxidation stability of 
CLNA isomers in each geometrical group was also dependent 
on the location of the three conjugated double bonds. Evaluating 
the oxidative stability of PSO (rich in PA) in Rancimat® system, 
the oxidation induction time for the PSO was 0.54 ± 0.05 and 
linseed oil (rich in LNA) was 0.67 ± 0.00 hours, which differed 
significantly from the soybean oil whose oxidation induction 
induction via lipoperoxidation (IGARASHI; MIYAZAWA, 2000; 
TSUZUKI et al., 2004a). 
It has already been found that different CLNA isomers 
exert different bioactivities (SUZUKI et al., 2001), but their 
mechanisms of action are unclear. Furthermore, studies have 
shown that CLNAs could be metabolized into CLA in vivo 
(TSUZUKI et al., 2004b, 2006; YUAN et al., 2009c) suggesting 
that the health benefits may be due to the CLA.
Weight gain, body composition, lipids  
profile, and insulin resistance index
Some studies report controversial results for the role of 
CLNAs in weight gain, body composition, plasma lipids, and 
insulin resistance index.
Koba et al. (2002) investigated how CLNAs affect 
body fat mass in rats and concluded that feeding CLNAs 
resulted in reduction in weight of adipose tissue. In contrast, 
supplementation with 1% CLNAs (α-ESA and/or PA) for 6 weeks 
did not significantly affect the food intake, body, and tissue 
weights of mice (YUAN et al., 2009c, e). Yamasaki et al. (2006) 
reported that body weight and adipose tissue were not affected 
in C57BL/6N mice fed experimental diets containing 0.12 
and 1.2% pomegranate seed oil (PSO) rich in PA for 3 weeks. 
Arao et al. (2004a) showed that feeding a diet supplemented with 
9% safflower oil and 1% PSO for two weeks did not affect the 
abdominal white adipose tissue weight in Otsuka Long-Evans 
Tokushima Fatty (OLETF) rats. However, Koba et al. (2002) 
showed that CLNAs reduce the perirenal adipose tissue weight 
in a larger extent when compared with LA, CLA, and LNA in 
Sprague-Dawley rats. The same group recently showed that 
supplementation with PSO decreased the weight of perirenal 
adipose tissue in ICR CD1 mice in a dose dependent manner 
after four weeks of feeding (KOBA et al., 2007). Chardigny et al. 
(2003) also found that calendic acid (trans8, trans10, cis12-18:3) 
significantly decreased the body fat content in male mice. 
Some studies have found that supplementation with 
CLNAs significantly decreases serum TC (KOBA et al., 2002; 
DHAR et al., 2006), apoB-100 (ARAO et al., 2004b), and 
hepatic TG (ARAO et al., 2004a, b). However, Yang et al. (2005) 
showed that feeding 12.2-12.7 g.kg-1 PA and α-ESA for 42 days 
did not affect serum TG, TC, HDL-C, and non-HDL-C levels, 
but it exhibited significant effects in decreasing the liver TC in 
hamsters. On the other hand, Yamasaki et al. (2006) reported 
significant increases in serum TG and phospholipid levels but 
not in TC in mice fed 0.12 and 1.2% PSO. Koba et al. (2007) did 
not find any significant effect of PA on serum lipids in mice, but 
the liver TG levels were significantly decreased when compared 
to the control group. This observation is in agreement with 
results by Yuan et al. (2009e) who did not observe significant 
differences in TG, TC, HDL-C and LDL-C levels in plasma 
among mice fed control diet or fed α-ESA or PA for six weeks 
either, but the liver TG levels were significantly decreased 
compared to the control group. 
There are few data on the effect of CLNAs on lipid profiles 
in human subjects. Mirmiran et al. (in press) concluded in their 
study that PSO consumption in hyperlipidaemic subjects did 
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Molecular actions
The regulation of molecular actions by natural dietary 
components represents an alternative therapeutic strategy in 
inflammatory disorders, bowel diseases, rheumatoid arthritis, 
atherosclerosis, metabolic syndrome, and ischemia/reperfusion 
injury that are recognized as major health problems worldwide. 
A common characteristic of these diseases is the excessive 
production of pro-inflammatory mediators such as TNFα, 
GM-CSF, IL-1, IL-6, IL-8, leukotriene B4, and PAF, the presence 
of highly activated inflammatory cells such as neutrophils, 
monocytes, and macrophages, and the excessive production 
of reactive oxygen species (ROS) (BOUSSETTA et al., 2009). 
These authors evaluated the effect of PA on TNFα-induced 
neutrophil hyperactivation in vitro and on colon inflammation 
in vivo and concluded that PA exerts a potent anti-inflammatory 
effect through the inhibition of TNFα-induced priming of ROS 
production and myeloperoxidase (MPO) release by neutrophils 
thus resulting in low tissue damage.
Bassaganya-Riera et al. (2010) observed in mice that PA 
intake upregulated colonic expression of PPAR δ, keratinocyte 
growth factor, and the orphan nuclear receptor RORγt 
expression and suppressed colonic and M1 macrophage-derived 
TNF-α. In the mesenteric lymph nodes (i.e., mucosal inductive 
sites), PA increased the levels of IL-17 and IFN-γ in CD8+ T cells. 
The authors provided molecular evidence in vivo suggesting that 
PA modulates mucosal immune responses and ameliorates gut 
inflammation through PPAR γ and δ-dependent mechanisms. In 
the same direction, Hontecillas et al. (2009) investigated whether 
the PA activates PPAR γ, an important therapeutic target for 
diabetes and inflammation. Dietary PA decreased fasting plasma 
glucose concentrations, improved the glucose-normalizing 
ability, suppressed NF-κB activation, TNF-α expression and 
upregulated PPAR α- and γ-responsive genes in skeletal muscle 
and adipose tissue of mice. Their findings demonstrated that 
PA binds and robustly activates PPAR γ, increases PPAR 
γ-responsive gene expression, which could be important to 
ameliorate diabetes and inflammation (HONTECILLAS et al., 
2009). The same authors have previously shown that dietary 
supplementation of mice with catalpic acid, another isomer of 
CLNA, upregulated PPAR α and PPAR α-responsive genes in 
white adipose tissue (WAT), whereas PPAR γ and δ expression 
were not significantly affected by catalpic acid in WAT. These 
data suggest that the metabolic effects of catalpic acid on 
glucose and lipid metabolism may be mediated through a 
PPAR α-dependent mechanism (HONTECILLAS et al., 2008). 
Moreover, studies show that bitter gourd seed oil (BGO), which 
contains a high level of cis9, trans11, trans13 CLNA, increases 
PPAR γ mRNA and protein levels in Caco-2 cells and in rats 
(KOHNO et al., 2004b; YASUI et al., 2005). Moreover, tung oil 
containing α-ESA activates PPAR γ in human endothelial cells 
of umbilical vein (TSUZUKI; KAWAKAMI, 2008).
Tran et al. (2010) evaluated pomegranate (Punica granatum) 
seed linolenic acid isomers as selective estrogen receptor 
modulators (SERMs) in vitro. PA inhibited (IC50) estrogen 
receptor (ER) α and β at 7.2 and 8.8 mM, respectively; α-ESA 
inhibited ERα/ERβ at 6.5/7.8 mM, so both PA and α-ESA are 
SERMs. Therefore, PA, as principal components of PSO, acts as 
time was 7.65 ± 1.19 hours. This result was expected since the 
PA and the LNA have greater degree of unsaturation in their 
structure which makes them more susceptible to oxidation 
(MELO et al., 2010). These results indicated that CLNAs may 
influence the oxidative deterioration of vegetable oils despite 
their presence (KINAMI et al., 2007).
The stability of PSO was also analyzed in the systems: 
testing radical 2,2-diphenyl-1-picrylhydrazyl (DPPH•) and co-
oxidation of β-carotene/linoleic acid. The results showed that 
the PSO was able to reduce the DPPH•, with IC50 (concentration 
capable to reduce 50% of the radical) of 3.77 mg, while that of 
Butilhydroxytolueno (BHT) was 0.26 mg. With regard to the 
system β-carotene/linoleic acid, the PSO had 21% of oxidation 
resistance (MELO et al., 2010). Schubert, Lansky and Neeman 
(1999) reported an approximately 40% inhibition of oxidation 
for the PSO; however the authors correlate this value with the 
presence of phenolic compounds with antioxidant activity.
In vivo, CLNAs increased the level of plasma hydroperoxide 
and live lipid oxidation significantly (NOGUCHI et al., 2001). 
In contrast, Dhar, Ghosh and Bhattacharyya (1999) have 
previously reported that the CLNA present in karela seed oil 
has scavenging action against lipid peroxidation, using the 
TBARS method, on rats for 4 weeks and that 0.5% α-ESA in 
the dietary lipid was the optimal dose. Mukherjee et al. (2002) 
examined the activity of PA supplemented in the diet of rats at 
various concentrations, and it also appeared to be efficient as an 
antioxidant, with maximum antioxidant activity of 0.6% PA. It 
is likely that under these conditions CLNAs may have reduced 
the formation of hydro-peroxides by lowering the formation 
of free radicals and peroxidation of PUFAs in erythrocyte 
membrane and other lipids; another possible explanation may 
be that the biohydrogenation or free radical addition to one of 
the conjugated double bonds of CLNAs might have taken place 
resulting in the formation of conjugated dienes that might have 
acted as antioxidants (DHAR; GHOSH; BHATTACHARYYA, 
1999; SAHA; GHOSH, 2009).
Dhar et al. (2006) investigated the dietary effect of CLNAs 
on lipid peroxidation in alloxan-induced diabetes mellitus 
in rats. LDL- and erythrocyte membrane lipid peroxidation 
were reduced significantly in each of the experimental groups 
(0.5% CLNAs, 0.15% α-tocopherol, and 0.25% CLNA + 
0.15% α-tocopherol) versus the control group. The CLNAs + 
α-tocopherol diet induced a greater reduction in the membrane 
lipid and liver lipid peroxidation than the α-tocopherol 
diet alone. 
Saha and Ghosh (2009) analyzed the influence of 
two isomers of CLNA (0.5% of total lipid given for 15 days) in 
antioxidant activity against arsenic induced oxidative stress. 
The result suggests that sodium arsenite changed the activities 
of antioxidant enzymes in the plasma, erythrocyte lysate, liver, 
and brain homogenate, while α-ESA and PA increased activities 
of SOD, CAT, and GSH-Px and decreased the activity of nitric 
oxide synthase (NOS) to normal level. Overall, there was some 
difference in the effectiveness of the two isomers, which is due 
to their antagonistic cis–trans molecular arrangement. In this 
study, α-ESA acid was more efficient as antioxidant than PA due 
to its higher trans content.
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and LNA and concluded that, CLAs and CLNAs had greater 
oxidative instability. Compared with CLAs, CLNAs was more 
susceptible to oxidative degradation implying that the oxidative 
stability of CFAs decreases with an increase in the number of 
conjugated double bonds.
5 Analysis methods
The biological activities showed in both cells and in vivo 
studies arouse interest to separate and identify these CFAs.
The multiple physiologic effects reported for CLAs could be 
the result of interactions of the biologically active CLA isomers 
with numerous metabolic signaling pathways. Hence, studies to 
define beneficial and detrimental effects of each individual CLA 
isomers are needed and should be undertaken (La FUENTE; 
LUNA; JUÁREZ, 2006). Like CLAs, CLNA isomers showed 
different physiologic effects, and minor structural differences 
among CLNA isomers make their separation, identification, 
and quantification difficult. In this regard, it is imperative to 
develop a reliable method of separation and characterization of 
individual CFA isomers in complex mixtures such as synthetic 
products and biological materials (CAO et al., 2006).
In CFAs analysis, it is important that the geometrical 
and positional isomers are separated and quantified avoiding 
additional isomerization during any derivatization steps 
(CHRISTIE; DOBSON; ADOLF, 2007). The traditional analysis 
of fatty acids from lipids involves derivatization to form less 
polar and more volatile compounds. Preparation of volatile 
derivatives is often the step prior to the fatty acids profile 
analysis by chromatography (La FUENTE; LUNA; JUÁREZ, 
2006). The most extended procedure consists in transforming 
fatty acids from glycerides into Methyl Esters (ME). Alkali-
catalyzed methylation methods (using NaOCH3 or KOH in 
methanol at room temperature) are considered the most reliable 
for determining the distribution of CFA isomers because they 
cause no isomerization and produce no methoxy artifacts. 
Acid-catalyzed methods, employing BF3, HCl or H2SO4, favor 
extensive isomerization of conjugated dienes and trienes and 
contribute to forming allylic methoxy artifacts (La FUENTE; 
LUNA; JUÁREZ, 2006; CHEN et al., 2007; SASSANO et al., 
2009).
Gas chromatography (GC) and silver-ion impregnated 
high-performance liquid chromatography (Ag ± HPLC) are 
the most common techniques in the analysis of CFA isomers 
(CHEN et al., 2007; CHRISTIE; DOBSON; ADOLF, 2007; 
SASSANO et al., 2009).
Analysis on capillary columns GC-FID (equipped with 
a flame ionization detector) and polar phases is the common 
approach used for the analysis of trans fatty acids, CP-Sil 88TM, 
SP2380TM or BPX-70TM (100 m). The most commonly gases 
used as carrier gas are Helium or Nitrogen (KRAMER et al., 2004; 
La FUENTE; LUNA; JUÁREZ, 2006; CHRISTIE; DOBSON; 
ADOLF, 2007; YANG et al., 2009). In addition, Ag ± HPLC 
has proved very useful for the separation of geometrical and 
positional isomers both on analytical and preparative scales 
using a silver ion-impregnated column and diode array detector 
SERMs and, potentially, will also act in the future as effective 
breast cancer chemopreventive agents.
These natural dietary compounds may provide a novel 
alternative therapeutic strategy in many diseases such as 
inflammatory diseases and cancer (BOUSSETTA et al., 2009).
4 CLAs versus CLNAs
The study performed by Plourde et al. (2006) demonstrated 
that an equimolar mixture of two CLNA isomers, cis9, trans11, 
cis15-18:3 and cis9, trans13, cis15-18:3 has the same apparent 
absorption efficiency than cis9, trans11-18:2 when ingested 
under nutritional and physiological conditions. According to 
Yuan et al. (2009c), the cis9, trans11-18:2 and trans10, cis12-18:2 
were incorporated into all mouse tissues examined in the CLAs 
group at levels ranging from 0.5 to 2.0% of tissue fatty acids, 
whereas the α-ESA and PA were detected in all mouse tissues 
examined in the α-ESA and PA groups, respectively, at levels 
ranging from 0.1 to 1.3%. Furthermore, CLAs were detected in 
all tissues examined in both α-ESA and PA groups with levels 
ranging from 0.5 to 3.5% of tissue fatty acids.
It was found that supplementation of CLNAs or CLAs in 
the maternal dietary fat at 1 and 2% levels in diet led to the 
incorporation of only 0.98 to 1.71% CLNAs in milk fat in rats, 
contrasting with the incorporation of 4.21 to 8.66% CLAs in 
milk fat, suggesting that both CLAs and CLNAs were able to 
transfer from maternal diet to the milk. These results showed 
that transfer of CLNAs from maternal diets was quantitatively 
minor compared with that of CLAs (CAO et al., 2009).
Studies show that CLNAs are more effective than CLAs 
in reducing body fat mass in rodents (KOBA et al., 2002, 
2007). However, Chardigny et al. (2003) found that calendic 
acid (trans8, trans10, cis12-18:3) significantly decreased the 
body fat content in male mice although it was less effective 
than trans10, cis12-18:2. Yuan et al. (2009e) reported that no 
significant differences in food intake and final body weight 
were observed among the groups of mice fed either a control 
diet or one of experimental diets supplemented with 1% α-ESA, 
1% PA, or 1% CLA in the form of TG for 6 weeks. In contrast, 
the weights of the perirenal and epididymal adipose tissues were 
significantly decreased while the liver TG level and weight was 
significantly increased in mice fed a diet supplemented with 
CLAs (YUAN et al., 2009e). Lam et al. (2008) examined the 
relative hypocholesterolemic activity of CLAs, CLNAs, and 
their corresponding nonconjugated, LA and LNA. They found 
that LA, CLAs and LNA were hypocholesterolemic, while 
CLNAs had no effect on blood cholesterol level in hamsters 
fed a high cholesterol diet. This could be explained, at least in 
part, because LA, CLA, and LNA, but not CLNA, inhibited 
intestinal cholesterol acyltransferase (ACAT) activity and 
interfered with neutral sterol absorption. Although the results 
are still contradictory and inconclusive, the findings seem to 
indicate that CLNAs modulate body fat and lipid metabolism 
differently from CLAs.
Yang et al. (2009) studied the oxidative stability of individual 
CLA and CLNA isomers comparing the oxidative stabilities 
with their corresponding nonconjugated counterparts, LA, 
Ciênc. Tecnol. Aliment., Campinas, 30(2): 295-307, abr.-jun. 2010304
Carvalho; Melo; Mancini-Filho
γ and δ-dependent mechanisms. The FASEB Journal, v. 24, n. 1, 
2010.
BENJAMIN, S.; SPENER, F. Conjugated linoleic acid as functional food: 
an insight into their health benefits. Nutrition and Metabolism, 
v. 6, p. 36-48, 2009.
BHATTACHARYA, A. et al. Biological effects of conjugated 
linoleic acids in health and disease. The Journal of Nutritional 
Biochemistry, v. 17, n. 12, p. 789-810, 2006.
BOTELHO, A. P.; SANTOS-ZAGO, L. F.; OLIVEIRA, A. C. Conjugated 
linoleic acid supplementation modified the body composition and 
serum leptin levels in weaning rats. Archivos Latinoamericanos de 
La Sociedad Latinoamericana de Nutrícion, v. 58, n. 2, p. 156-163, 
2008.
BOUSSETTA, T. et al. Punicic Acid a Conjugated Linolenic Acid 
Inhibits TNFα-Induced Neutrophil Hyperactivation and Protects 
from Experimental Colon Inflammation in Rats. PLoS ONE, v. 4, 
n. 7, p. e6458-e6469, 2009.
BRASIL. Ministério da Saúde. Agência Nacional de Vigilância Sanitária 
– ANVISA. Resolução nº 833, 28 de março de 2007. Resolve 
Determinar a apreensão, em todo território nacional, de todos os 
lotes do produto ácido linoléico conjugado - CLA, por não possuir 
registro no Ministério da Saúde. Diário Oficial da União, Brasília, 
DF, 29 mar. 2007. Seção 1, p. 68. Disponível em: <http://elegis.anvisa.
gov.br/leisref/public/showAct.php?id=26272&mode=PRINT_
VERSION>. Acesso em: 14 mar. 2010.
CAO, Y. et al. Differential incorporation of dietary conjugated linolenic 
and linoleic acids into milk lipids and liver phospholipids in 
lactating and suckling rats. Journal of Nutritional Biochemistry, 
v. 20, n. 9, p. 685-693, 2009. 
CAO, Y. et al. Identification and Characterization of Conjugated 
Linolenic Acid Isomers by Ag+-HPLC and NMR. Journal of 
Agricultural and Food Chemistry, v. 54, n. 24, p. 9004-9009, 
2006.
CARVALHO, E. B. T. et al. In vivo evaluation of the effect of 
supplementation of isomers of conjugated linoleic acid (CLAs). 
Brazilian Journal of Pharmaceutical Sciences, v. 45, sup. 1, p. 41, 
2009.
CHARDIGNY, J. M. et al. Effect of Conjugated FA on Feed Intake, 
Body Composition, and Liver FA in Mice. Lipids, v. 38, n. 9, 
p. 895-902, 2003. 
CHEN, J. et al. Isomerization of conjugated linolenic acids during 
methylation. Chemistry and Physics of Lipids, v. 150, n. 2, 
p. 136-142, 2007.
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the Isolation, Analysis and Identification of Conjugated Linoleic 
Acid. Lipids, v. 42, n. 12, p. 1073-1084, 2007.
COAKLEY, M. et al. Inhibitory Effect of Conjugated α-Linolenic Acid 
from Bifidobacteria of Intestinal Origin on SW480 Cancer Cells. 
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CZAUDERNA, M.; KOWALCZYK, J.; KORNILUK, K. Effect of dietary 
conjugated linoleic acid and selenized yeast on the concentration 
of fatty acids and minerals in rats. Archives of Animal Nutrition, 
v. 61, n. 2, p. 135-150, 2007.
DHAR, P. et al. Dietary Comparison of Conjugated Linolenic Acid 
(9cis, 11trans, 13trans) and α-Tocopherol Effects on Blood Lipids 
and Lipid Peroxidation in Alloxan-Induced Diabetes Mellitus in 
Rats. Lipids, v. 41, n. 1, p. 49-54, 2006.
DHAR, P.; GHOSH, S.; BHATTACHARYYA, D. K. Dietary effects of 
conjugated octadecatrienoic fatty acid (9cis, 11trans, 13trans) levels 
on blood lipids and nonenzymatic in vitro lipid peroxidation in rats. 
Lipids, v. 34, n. 2, p. 109-114, 1999.
(KRAMER et al., 2004; CAO et al., 2006; CHRISTIE; DOBSON; 
ADOLF, 2007; SASSANO et al., 2009). 
Fatty acid methyl esters (FAMEs) are identified by 
comparison of their retention times with individual reference 
Standards. The CLNAs are identified using the major fatty 
acid extracted from their corresponding oils with hexane 
and esterified to the methyl esters (KÝRALAN; GÖLÜKCÜ; 
TOKGÖZ, 2009). Furthermore, a known amount of internal 
standard (for example, C17:0) is added to each test sample fatty 
acid (TSUZUKI et al., 2004a).
However, to resolve and determine individual CLNA 
isomers present in natural mixtures that have only minor 
positional and geometrical differences in their structure, the 
separation and confirmation of all (seven) isomer forms by GC 
analysis is difficult. Thus, a combination of gas chromatography-
mass spectrometry (GC–MS) or characterization by nuclear 
magnetic resonance (1H NMR or 13C NMR) is necessary 
(CAO et al., 2006; SASSANO et al., 2009). 
6 Conclusions
There are no consensus in the literature regarding the effects 
of CFAs on animal and human organisms. Animal studies are 
inconclusive and often contradictory, and human studies are 
scarce. In addition, some effects observed in animal studies are 
not the same verified in humans. Although the marketing of 
supplements containing CLAs have been banned by ANVISA 
in Brazil, in some continental Europe countries, their use is 
not restricted. Therefore, further studies are needed in order to 
elucidate the mechanisms and physiological effects of the CFAs 
to provide greater safety and establish recommendations with 
respect to their use.
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